ロード中...
NEO adjuvant chemotherapy in breast cancer: What have we learned so far?
Neoadjuvant chemotherapy (NACT) in breast cancer has undergone continuous evolution over the last few decades to establish its role in the combined modality management of these tumors. The process of evolution is still far from over. Many questions are still lurking in the minds of oncologists treat...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Medknow Publications
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2941606/ https://ncbi.nlm.nih.gov/pubmed/20931014 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0971-5851.68846 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|